切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (09) : 656 -659. doi: 10.3877/cma.j.issn.1672-6448.2017.09.005

所属专题: 文献

综述

弥散加权成像在经直肠超声引导前列腺目标穿刺中的应用研究进展
闫雷1, 戚庭月1,()   
  1. 1. 225012 扬州大学附属医院 扬州市第一人民医院超声科
  • 收稿日期:2017-03-15 出版日期:2017-09-01
  • 通信作者: 戚庭月
  • 基金资助:
    江苏省科技厅临床医学科技专项基金(BL2014064)

Advances in the application of diffusion weighted imaging-targeted prostate biopsy guided by transrectal ultrasonography

Lei Yan1, Tingyue Qi1()   

  • Received:2017-03-15 Published:2017-09-01
  • Corresponding author: Tingyue Qi
引用本文:

闫雷, 戚庭月. 弥散加权成像在经直肠超声引导前列腺目标穿刺中的应用研究进展[J]. 中华医学超声杂志(电子版), 2017, 14(09): 656-659.

Lei Yan, Tingyue Qi. Advances in the application of diffusion weighted imaging-targeted prostate biopsy guided by transrectal ultrasonography[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(09): 656-659.

[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2]
DeSantis CE, Siegel RL, Sauer AG, et al. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities [J]. CA Cancer J Clin, 2016, 66(4):290-308.
[3]
Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias [J]. Ann Oncol, 2016, 27(4):725-731.
[4]
Ukimura O, Coleman JA, de la Taille A, et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care [J]. Eur Urol, 2013, 63(2):214-230.
[5]
Chondros K, Karpathakis N, Heretis I, et al. Validation of revised Epstein′s criteria for insignificant prostate cancer prediction in a Greek subpopulation [J]. Hippokratia, 2015, 19(1):30-33.
[6]
Salami SS, Ben-Levi E, Yaskiv O, et al. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? [J]. BJU Int, 2015, 115(4):562-570.
[7]
Wu J, Ji A, Xie B, et al. Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis [J]. Oncotarget, 2015, 6(41):43571-43580.
[8]
Nassiri N, Natarajan S, Margolis DJ, et al. Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology [J]. Urology, 2015, 86(3):432-438.
[9]
Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging-Reporting and Data System: 2015, Version 2 [J]. Eur Urol, 2016, 69(1):16-40.
[10]
中华医学会放射学分会,中华医学会影像技术分会. MRI检查技术专家共识 [J]. 中华放射学杂志, 2016, 50(10):724-739.
[11]
Janesya Sutedjo, 陈慧铀, 姜亮, 等.The progress of diffusion-weighted MRI application in prostate cancer diagnosis [J]. 磁共振成像, 2015, 6(7):554-560.
[12]
Bourne R, Panagiotaki E. Limitations and Prospects for Diffusion-Weighted MRI of the Prostate [J]. Diagnostics, 2016, 6(2):21.
[13]
Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer [J]. Radiology, 2011, 259(2):453-461.
[14]
Verma S, Rajesh A, Morales H, et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy [J]. AJR Am J Roentgenol, 2011, 196(2):374-381.
[15]
Sadinski M, Karczmar G, Peng Y, et al. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score [J]. AJR Am J Roentgenol, 2016, 207(3):592-598.
[16]
杨正汉,冯逢,王霄英. 磁共振成像技术指南: 检查规范、临床策略及新技术应用 [M]. 北京: 人民军医出版社, 2010: 268-269
[17]
Tamada T, Kanomata N, Sone T, et al. High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness [J]. PLoS One, 2014, 9(5):e96619.
[18]
Manenti G, Nezzo M, Chegai F, et al. DWI of Prostate Cancer: Optimal b-Value in Clinical Practice [J]. Prostate Cancer, 2014:868269.
[19]
Zhang K, Shen Y, Zhang X, et al. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker [J]. PLoS One, 2016, 11(3):e0151176.
[20]
Bittencourt LK, Attenberger UI, Lima D, et al. Feasibility study of computed vs measured high b-value (1400 s/mm2) diffusion-weighted MR images of the prostate [J]. World J Radiol, 2014, 6(6):374-380.
[21]
Vural M, Ertas G, Onay A, et al. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000 [J]. Biomed Res Int, 2014:768291.
[22]
张杨贵,陈珊红,温志玲, 等. 体素内不相干运动MRI与DWI对前列腺癌的诊断 [J]. 中国CT和MRI杂志, 2016, 14(3):78-80.
[23]
Vargas HA, Lawrence EM, Mazaheri Y, et al. Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer [J]. World J Radiol, 2015, 7(8):184-188.
[24]
Sharif-Afshar AR, Nguyen C, Feng TS, et al. Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients [J]. EBioMedicine, 2016, 7:80-84.
[25]
Medved M, Soylu-Boy FN, Karademir I, et al. High-resolution diffusion-weighted imaging of the prostate [J]. AJR Am J Roentgenol, 2014, 203(1):85-90.
[26]
王奕,林园凯,周长圣, 等. 小视野弥散加权成像在前列腺癌诊断中的应用价值 [J]. 医学研究生学报, 2016, 29(4):395-400.
[27]
Korn N, Kurhanewicz J, Banerjee S, et al. Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection [J]. Magn Reson Imaging, 2015, 33(1):56-62.
[28]
Bjurlin MA, Mendhiratta N, Wysock JS, et al. Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment [J]. Cent European J Urol, 2016, 69(1):9-18.
[29]
van de Ven WJ, Venderink W, Sedelaar JP, et al. MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience [J]. Int Urol Nephrol, 2016, 48(7):1037-1045.
[30]
Lai WJ, Wang HK, Liu HT, et al. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results [J]. J Chin Med Assoc, 2016, 79(11):618-624.
[31]
Lee DJ, Recabal P, Sjoberg DD, et al. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study [J]. J Urol, 2016, 196(3):697-702.
[32]
Wang Y, Ni D, Qin J, et al. Patient-specific Deformation Modelling via Elastography: Application to Image-guided Prostate Interventions [J]. Sci Rep, 2016, 6:27386.
[33]
Baco E, Rud E, Eri LM, et al. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy [J]. Eur Urol, 2016, 69(1):149-156.
[34]
戚庭月,陈亚青,苗华栋, 等. 经DWI定位经直肠超声引导下前列腺穿刺活检术诊断前列腺癌 [J]. 中国医学影像技术, 2011, 27(7):1485-1489.
[35]
王辉清,肖广安,杨波, 等. MRI分区定位联合经直肠B超引导前列腺穿刺活检在前列腺癌诊断中的应用 [J]. 第二军医大学学报, 2015, 36(5):522-524.
[36]
Lee DH, Nam JK, Park SW, et al. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL [J]. Yonsei Med J, 2016, 57(3):565-571.
No related articles found!
阅读次数
全文


摘要